Mark R. Brann

Chemical genomics: massively parallel technologies for rapid lead identification and target validation

Uli Hacksell, Norman Nash, Ethan S. Burstein, 2004, Cytotechnology.

Pharmacological and Behavioral Profile of N-(4-Fluorophenylmethyl)-N-(1-methylpiperidin-4-yl)-N′-(4-(2-methylpropyloxy)phenylmethyl) Carbamide (2R,3R)-Dihydroxybutanedioate (2:1) (ACP-103), a Novel 5-Hydroxytryptamine2A Receptor Inverse Agonist

Ethan S. Burstein, Fabrice Piu, Mark R. Brann, 2006, Journal of Pharmacology and Experimental Therapeutics.

Discovery of the first nonpeptide agonist of the GPR14/urotensin-II receptor: 3-(4-chlorophenyl)-3-(2- (dimethylamino)ethyl)isochroman-1-one (AC-7954).

Ethan S. Burstein, Mark R. Brann, Roger Olsson, 2002 .

The Dopamine D1 Receptors

Philip Seeman, Mark R. Brann, P. Seeman, 1992 .